VR医学
Online ISSN : 2187-2201
Print ISSN : 1347-9342
18 巻, 1 号
選択された号の論文の2件中1~2を表示しています
応用論文
  • Masako Kanai-Pak, Shuichi Kawano, Masahiro Kunichika, Hiroshi Oyama
    2021 年 18 巻 1 号 p. 1-8
    発行日: 2021/12/01
    公開日: 2022/12/01
    ジャーナル フリー

    This paper introduces the development of a VR program of interview scenes for nurse managers. The contents include four scenarios which nurse managers often encounter. Twenty-two nurse managers participated in its verification. Ninety percent of the participants answered “agree” or “strongly agree” regarding “helpful,” “useful for the future,” and “interesting.” Due to COVID-19, the participants watched the VR program either at their home or work places. All the discussions were held online. Even during the state of emergency, it is confirmed that a VR program can be useful tool for training and education.

Original Paper
  • Wey Guan Lem, Ayako Kohyama-Koganeya, Toki Saito, Hiroshi Oyama
    2021 年 18 巻 1 号 p. 9-19
    発行日: 2021/12/01
    公開日: 2022/12/01
    ジャーナル フリー

    Background: The public stigma of depression can lead to unemployment and self-stigmatization for the patient with depression. Contact-based educational intervention is one of the most effective interventions to reduce depression stigma. However, contact using an actual patient is difficult to arrange and is ethically challenging. Virtual reality (VR) technology could reduce the stigma of depression by allowing users to interact with virtual patients. This study aimed to develop a support tool (VR-based anti-stigma: VRAS) for learning about depression and stigma for depression using virtual patients. Methods: A rapid prototyping method was adopted to develop the VRAS application using Unity3D (Unity Technologies, San Francisco, CA). The subjects were adults without mental illness. A questionnaire modified from a web-based learning tool (WBLT) evaluation scale was used to measure usefulness, comprehensibility, usability, and VR sickness. Results: Sixteen participants were recruited using snowball sampling and experienced the VRAS application. Of the participants, 81.3% rated the application positively for usefulness. All participants gave positive ratings for comprehensibility and usability. 56.2% of the participants experienced mild VR sickness. Conclusion: The VRAS application could be a user-friendly and helpful tool for learning about the stigma of depression. Future randomized controlled trials are needed to validate its effectiveness.

feedback
Top